IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

SR One Capital Management, LP

Q4 2021 Holdings

Filed 2022-02-14 | 2 holdings | $177.0K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Design Therapeutics Inc(DSGN)COM25056L103$120.5K5,626,47668.1%
Effector Therapeutics IncCOM28202V108$56.5K6,822,11431.9%